Larimar Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
LRMR on Nasdaq
Location
Three Bala Plaza East. Suite 506, Bala Cynwyd, PA

Insiders trading volume in the past year

Larimar Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Flynn Director, * Director by Deputization, 10%+ Owner $95.8M +$30M +45.6% Jul 31, 2025
Deerfield Partners, L.P. Director, Dir. by Deputization/10% Group, 10%+ Owner $10.4M Sep 16, 2022
Thomas Edward Hamilton Director $6.33M May 13, 2025
Maimon Carole Ben President and CEO, Director $3.49M Jan 22, 2025
Michael Celano Chief Financial Officer $1.56M Jan 22, 2025
Gopi Shankar Chief Development Officer $444K Jan 22, 2025
Russell Clayton Chief Medical Officer $400K Jan 22, 2025
Thomas O. Daniel Director May 12, 2021
Jonathan S. Leff Director May 13, 2025
Jeffrey W. Sherman Director May 13, 2025
Frank E. Thomas Director May 13, 2025
Joseph Truitt Director May 13, 2025
Peter Barrett Director May 10, 2022

Recent Insider Transactions by Companies or Individuals for Larimar Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.